Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Human Immunodeficiency Virus | Research

The dynamic risk factors of cardiovascular disease among people living with HIV: a real-world data study

Authors: Ziang Liu, Jiajia Zhang, Xueying Yang, Haoyuan Gao, Shujie Chen, Sharon Weissman, Bankole Olatosi, Xiaoming LI

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

This study aims to investigate the incidence and dynamic risk factors for cardiovascular diseases (CVD) among people living with HIV (PLWH).

Methods

In this population-based statewide cohort study, we utilized integrated electronic health records data to identify adult (age ≥ 18) who were diagnosed with HIV between 2006 and 2019 and were CVD event-free at the HIV diagnosis in South Carolina. The associations of HIV-related factors and traditional risk factors with the CVD incidence were investigated during the overall study period, and by different follow-up periods (i.e., 0-5yrs, 6-10yrs 11-15yrs) using multivariable logistic regression models.

Results

Among 9,082 eligible participants, the incidence of CVD was 18.64 cases per 1000 person-years. Overall, conventional risk factors, such as tobacco use, hypertension, obesity, chronic kidney disease (CKD), were persistently associated with the outcome across all three groups. While HIV-related factors, such as recent CD4 count (e.g., > 350 vs. <200 cells/mm3: adjusted odds ratio [aOR] range: 0.18–0.25), and percent of years in retention (e.g., 31–75% vs. 0–30%: aOR range: 0.24–0.57) were associated with lower odds of CVD incidence regardless of different follow up periods. The impact of the percent of days with viral suppression gradually diminished as the follow-up period increased.

Conclusions

Maintaining an optimal viral suppression might prevent CVD incidence in the short term, whereas restoring immune recovery may be beneficial for reducing CVD risk regardless of the duration of HIV diagnosis. Our findings suggest the necessity of conducting more targeted interventions during different periods of HIV infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Trickey A, Sabin CA, Burkholder G, Crane H, d’Arminio Monforte A, Egger M, Gill MJ, Grabar S, Guest JL, Jarrin I, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV. 2023;10(5):e295–307.CrossRefPubMedPubMedCentral Trickey A, Sabin CA, Burkholder G, Crane H, d’Arminio Monforte A, Egger M, Gill MJ, Grabar S, Guest JL, Jarrin I, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV. 2023;10(5):e295–307.CrossRefPubMedPubMedCentral
2.
go back to reference Barnes RP, Lacson JCA, Bahrami H. HIV infection and risk of Cardiovascular diseases Beyond Coronary Artery Disease. Curr Atheroscler Rep. 2017;19(5):20.CrossRefPubMedPubMedCentral Barnes RP, Lacson JCA, Bahrami H. HIV infection and risk of Cardiovascular diseases Beyond Coronary Artery Disease. Curr Atheroscler Rep. 2017;19(5):20.CrossRefPubMedPubMedCentral
3.
4.
go back to reference Xu Y, Chen X, Wang K. Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. (1878–7436 (Electronic)). Xu Y, Chen X, Wang K. Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. (1878–7436 (Electronic)).
5.
go back to reference McGettrick P, Mallon PWG, Sabin CA. Cardiovascular disease in HIV patients: recent advances in predicting and managing risk. Expert Rev Anti-infective Therapy. 2020;18(7):677–88.CrossRefPubMed McGettrick P, Mallon PWG, Sabin CA. Cardiovascular disease in HIV patients: recent advances in predicting and managing risk. Expert Rev Anti-infective Therapy. 2020;18(7):677–88.CrossRefPubMed
6.
go back to reference Feinstein MJ, Bahiru E, Achenbach C, Longenecker CT, Hsue P, So-Armah K, Freiberg MS, Lloyd-Jones DM. Patterns of Cardiovascular Mortality for HIV-Infected adults in the United States: 1999 to 2013. Am J Cardiol. 2016;117(2):214–20.CrossRefPubMed Feinstein MJ, Bahiru E, Achenbach C, Longenecker CT, Hsue P, So-Armah K, Freiberg MS, Lloyd-Jones DM. Patterns of Cardiovascular Mortality for HIV-Infected adults in the United States: 1999 to 2013. Am J Cardiol. 2016;117(2):214–20.CrossRefPubMed
7.
go back to reference Lang R, Humes E, Hogan B, Lee J, D’Agostino R, Massaro J, Kim A, Meigs JB, Borowsky L, He W, et al. Evaluating the Cardiovascular risk in an Aging Population of people with HIV: the impact of Hepatitis C Virus Coinfection. J Am Heart Association. 2022;11(19):e026473.CrossRef Lang R, Humes E, Hogan B, Lee J, D’Agostino R, Massaro J, Kim A, Meigs JB, Borowsky L, He W, et al. Evaluating the Cardiovascular risk in an Aging Population of people with HIV: the impact of Hepatitis C Virus Coinfection. J Am Heart Association. 2022;11(19):e026473.CrossRef
8.
go back to reference Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V. HIV Infection and Incidence of Cardiovascular Diseases: An Analysis of a Large Healthcare Database. (2047–9980 (Electronic)). Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V. HIV Infection and Incidence of Cardiovascular Diseases: An Analysis of a Large Healthcare Database. (2047–9980 (Electronic)).
9.
go back to reference Silverberg MJ, Leyden WA, Xu L, Horberg MA, Chao CR, Towner WJ, Hurley LB, Quesenberry CP Jr., Klein DB. Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr. 2014;65(2):160–6.CrossRefPubMed Silverberg MJ, Leyden WA, Xu L, Horberg MA, Chao CR, Towner WJ, Hurley LB, Quesenberry CP Jr., Klein DB. Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr. 2014;65(2):160–6.CrossRefPubMed
10.
go back to reference Drozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, Burkholder GA, Mathews WC, Silverberg MJ, Sterling TR, et al. Increased risk of myocardial infarction in HIV-Infected individuals in North America compared with the General Population. J Acquir Immune Defic Syndr. 2017;75(5):568–76.CrossRefPubMedPubMedCentral Drozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, Burkholder GA, Mathews WC, Silverberg MJ, Sterling TR, et al. Increased risk of myocardial infarction in HIV-Infected individuals in North America compared with the General Population. J Acquir Immune Defic Syndr. 2017;75(5):568–76.CrossRefPubMedPubMedCentral
11.
go back to reference Jaschinski N, Greenberg L, Neesgaard B, Miró JM, Grabmeier-Pfistershammer K, Wandeler G, Smith C, De Wit S, Wit F, Pelchen-Matthews A et al. Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV. AIDS 2023, 37(3). Jaschinski N, Greenberg L, Neesgaard B, Miró JM, Grabmeier-Pfistershammer K, Wandeler G, Smith C, De Wit S, Wit F, Pelchen-Matthews A et al. Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV. AIDS 2023, 37(3).
12.
go back to reference Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, Longenecker CT, Strachan F, Bagchi S, Whiteley W, et al. Global Burden of Atherosclerotic Cardiovascular Disease in people living with HIV. Circulation. 2018;138(11):1100–12.CrossRefPubMedPubMedCentral Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, Longenecker CT, Strachan F, Bagchi S, Whiteley W, et al. Global Burden of Atherosclerotic Cardiovascular Disease in people living with HIV. Circulation. 2018;138(11):1100–12.CrossRefPubMedPubMedCentral
13.
go back to reference Jeffrey L, Sonia E, Jasimuddin A. HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies. Open Heart. 2018;5(2):e000823.CrossRef Jeffrey L, Sonia E, Jasimuddin A. HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies. Open Heart. 2018;5(2):e000823.CrossRef
14.
go back to reference Freiberg MS, Chang CH, Skanderson M, Patterson OV, DuVall SL, Brandt CA, So-Armah KA, Vasan RS, Oursler KA, Gottdiener J, et al. Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: results from the veterans Aging Cohort Study. JAMA Cardiol. 2017;2(5):536–46.CrossRefPubMedPubMedCentral Freiberg MS, Chang CH, Skanderson M, Patterson OV, DuVall SL, Brandt CA, So-Armah KA, Vasan RS, Oursler KA, Gottdiener J, et al. Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: results from the veterans Aging Cohort Study. JAMA Cardiol. 2017;2(5):536–46.CrossRefPubMedPubMedCentral
15.
go back to reference Neesgaard B, Greenberg L, Miró JM, Grabmeier-Pfistershammer K, Wandeler G, Smith C, De Wit S, Wit F, Pelchen-Matthews A, Mussini C, et al. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium. Lancet HIV. 2022;9(7):e474–85.CrossRefPubMed Neesgaard B, Greenberg L, Miró JM, Grabmeier-Pfistershammer K, Wandeler G, Smith C, De Wit S, Wit F, Pelchen-Matthews A, Mussini C, et al. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium. Lancet HIV. 2022;9(7):e474–85.CrossRefPubMed
16.
go back to reference Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, Butt AA, Bidwell Goetz M, Leaf D, Oursler KA, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614–22.CrossRefPubMedPubMedCentral Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, Butt AA, Bidwell Goetz M, Leaf D, Oursler KA, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614–22.CrossRefPubMedPubMedCentral
17.
go back to reference Hyle EP, Mayosi BM, Middelkoop K, Mosepele M, Martey EB, Walensky RP, Bekker L-G, Triant VA. The association between HIV and atherosclerotic cardiovascular disease in sub-saharan Africa: a systematic review. BMC Public Health. 2017;17(1):954.CrossRefPubMedPubMedCentral Hyle EP, Mayosi BM, Middelkoop K, Mosepele M, Martey EB, Walensky RP, Bekker L-G, Triant VA. The association between HIV and atherosclerotic cardiovascular disease in sub-saharan Africa: a systematic review. BMC Public Health. 2017;17(1):954.CrossRefPubMedPubMedCentral
18.
go back to reference Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013;57(8):1164–71.CrossRefPubMed Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013;57(8):1164–71.CrossRefPubMed
19.
go back to reference Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A, de Wolf F, Hallett TB. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810–8.CrossRefPubMedPubMedCentral Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A, de Wolf F, Hallett TB. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810–8.CrossRefPubMedPubMedCentral
20.
21.
go back to reference Reddy KP, Parker RA, Losina E, Baggett TP, Paltiel AD, Rigotti NA, Weinstein MC, Freedberg KA, Walensky RP. Impact of cigarette smoking and Smoking Cessation on Life Expectancy among people with HIV: a US-Based modeling study. J Infect Dis. 2016;214(11):1672–81.CrossRefPubMedPubMedCentral Reddy KP, Parker RA, Losina E, Baggett TP, Paltiel AD, Rigotti NA, Weinstein MC, Freedberg KA, Walensky RP. Impact of cigarette smoking and Smoking Cessation on Life Expectancy among people with HIV: a US-Based modeling study. J Infect Dis. 2016;214(11):1672–81.CrossRefPubMedPubMedCentral
22.
go back to reference Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fätkenheuer G, Costagliola D, d’Arminio A, Cavassini M, Smith C, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. Aids. 2015;29(2):221–9.CrossRefPubMed Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fätkenheuer G, Costagliola D, d’Arminio A, Cavassini M, Smith C, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. Aids. 2015;29(2):221–9.CrossRefPubMed
23.
go back to reference Krishnan S, Schouten JT, Atkinson B, Brown TT, Wohl DA, McComsey GA, Glesby MJ, Shikuma C, Haubrich R, Jacobson DL. Changes in metabolic syndrome status after initiation of antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;68(1):73–80.CrossRefPubMedPubMedCentral Krishnan S, Schouten JT, Atkinson B, Brown TT, Wohl DA, McComsey GA, Glesby MJ, Shikuma C, Haubrich R, Jacobson DL. Changes in metabolic syndrome status after initiation of antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;68(1):73–80.CrossRefPubMedPubMedCentral
24.
go back to reference Armah KA, Chang CC, Baker JV, Ramachandran VS, Budoff MJ, Crane HM, Gibert CL, Goetz MB, Leaf DA, McGinnis KA, et al. Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veterans. Clin Infect Dis. 2014;58(1):121–9.CrossRefPubMed Armah KA, Chang CC, Baker JV, Ramachandran VS, Budoff MJ, Crane HM, Gibert CL, Goetz MB, Leaf DA, McGinnis KA, et al. Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veterans. Clin Infect Dis. 2014;58(1):121–9.CrossRefPubMed
25.
go back to reference Tien PC, Schneider MF, Cox C, Karim R, Cohen M, Sharma A, Young M, Glesby MJ. Association of HIV infection with incident diabetes mellitus: impact of using hemoglobin A1C as a criterion for diabetes. J Acquir Immune Defic Syndr. 2012;61(3):334–40.CrossRefPubMedPubMedCentral Tien PC, Schneider MF, Cox C, Karim R, Cohen M, Sharma A, Young M, Glesby MJ. Association of HIV infection with incident diabetes mellitus: impact of using hemoglobin A1C as a criterion for diabetes. J Acquir Immune Defic Syndr. 2012;61(3):334–40.CrossRefPubMedPubMedCentral
26.
go back to reference Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, Prins M, Reiss P. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59(12):1787–97.CrossRefPubMed Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, Prins M, Reiss P. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59(12):1787–97.CrossRefPubMed
27.
go back to reference Pyarali F, Iordanov R, Ebner B, Grant J, Vincent L, Toirac A, Haque T, Zablah G, Kapoor K, Powell A, et al. Cardiovascular disease and prevention among people living with HIV in South Florida. Med (Baltim). 2021;100(28):e26631.CrossRef Pyarali F, Iordanov R, Ebner B, Grant J, Vincent L, Toirac A, Haque T, Zablah G, Kapoor K, Powell A, et al. Cardiovascular disease and prevention among people living with HIV in South Florida. Med (Baltim). 2021;100(28):e26631.CrossRef
28.
go back to reference Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V. HIV infection and incidence of Cardiovascular diseases: an analysis of a large Healthcare Database. J Am Heart Association. 2019;8(14):e012241.CrossRef Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V. HIV infection and incidence of Cardiovascular diseases: an analysis of a large Healthcare Database. J Am Heart Association. 2019;8(14):e012241.CrossRef
29.
go back to reference Olatosi B, Zhang J, Weissman S, Hu J, Haider MR, Li X. Using big data analytics to improve HIV medical care utilisation in South Carolina: a study protocol. BMJ Open. 2019;9(7):e027688.CrossRefPubMedPubMedCentral Olatosi B, Zhang J, Weissman S, Hu J, Haider MR, Li X. Using big data analytics to improve HIV medical care utilisation in South Carolina: a study protocol. BMJ Open. 2019;9(7):e027688.CrossRefPubMedPubMedCentral
30.
go back to reference Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE. 2013;8(12):e81355.CrossRefPubMedPubMedCentral Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE. 2013;8(12):e81355.CrossRefPubMedPubMedCentral
31.
go back to reference Friis-Møller N, Thiébaut R, Reiss P, Weber R, D’Arminio Monforte A, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on adverse effects of Anti-HIV drugs study. Eur J Cardiovasc Prev Rehabilitation. 2010;17(5):491–501.CrossRef Friis-Møller N, Thiébaut R, Reiss P, Weber R, D’Arminio Monforte A, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on adverse effects of Anti-HIV drugs study. Eur J Cardiovasc Prev Rehabilitation. 2010;17(5):491–501.CrossRef
32.
go back to reference McLaughlin MM, Ma Y, Scherzer R, Rahalkar S, Martin JN, Mills C, Milush J, Deeks SG, Hsue PY. Association of viral persistence and atherosclerosis in adults with treated HIV infection. JAMA Netw Open. 2020;3(10):e2018099–2018099.CrossRefPubMedPubMedCentral McLaughlin MM, Ma Y, Scherzer R, Rahalkar S, Martin JN, Mills C, Milush J, Deeks SG, Hsue PY. Association of viral persistence and atherosclerosis in adults with treated HIV infection. JAMA Netw Open. 2020;3(10):e2018099–2018099.CrossRefPubMedPubMedCentral
33.
go back to reference Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Obel N, Gerstoft J. CD4 decline is Associated with increased risk of Cardiovascular Disease, Cancer, and death in virally suppressed patients with HIV. Clin Infect Dis. 2013;57(2):314–21.CrossRefPubMed Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Obel N, Gerstoft J. CD4 decline is Associated with increased risk of Cardiovascular Disease, Cancer, and death in virally suppressed patients with HIV. Clin Infect Dis. 2013;57(2):314–21.CrossRefPubMed
34.
go back to reference Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, Tedaldi EM, Wood K, Holmberg SD, Brooks JT. Low CD4 + T cell count is a risk factor for Cardiovascular Disease events in the HIV Outpatient Study. Clin Infect Dis. 2010;51(4):435–47.CrossRefPubMed Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, Tedaldi EM, Wood K, Holmberg SD, Brooks JT. Low CD4 + T cell count is a risk factor for Cardiovascular Disease events in the HIV Outpatient Study. Clin Infect Dis. 2010;51(4):435–47.CrossRefPubMed
35.
go back to reference Kelso NE, Sheps DS, Cook RL. The association between alcohol use and cardiovascular disease among people living with HIV: a systematic review. Am J Drug Alcohol Abus. 2015;41(6):479–88. Kelso NE, Sheps DS, Cook RL. The association between alcohol use and cardiovascular disease among people living with HIV: a systematic review. Am J Drug Alcohol Abus. 2015;41(6):479–88.
36.
go back to reference Triant VA, Regan S, Lee H, Sax PE, Meigs JB, Grinspoon SK. Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system. J Acquir Immune Defic Syndr. 2010;55(5):615–9.CrossRefPubMedPubMedCentral Triant VA, Regan S, Lee H, Sax PE, Meigs JB, Grinspoon SK. Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system. J Acquir Immune Defic Syndr. 2010;55(5):615–9.CrossRefPubMedPubMedCentral
37.
go back to reference Vedanthan R, Kamano JH, Bloomfield GS, Manji I, Pastakia S, Kimaiyo SN. Engaging the entire Care Cascade in Western Kenya: a model to achieve the Cardiovascular Disease secondary Prevention Roadmap goals. Glob Heart. 2015;10(4):313–7.CrossRefPubMed Vedanthan R, Kamano JH, Bloomfield GS, Manji I, Pastakia S, Kimaiyo SN. Engaging the entire Care Cascade in Western Kenya: a model to achieve the Cardiovascular Disease secondary Prevention Roadmap goals. Glob Heart. 2015;10(4):313–7.CrossRefPubMed
38.
go back to reference Feinstein MJ, Bogorodskaya M, Bloomfield GS, Vedanthan R, Siedner MJ, Kwan GF, Longenecker CT. Cardiovascular complications of HIV in endemic countries. Curr Cardiol Rep. 2016;18(11):113.CrossRefPubMedPubMedCentral Feinstein MJ, Bogorodskaya M, Bloomfield GS, Vedanthan R, Siedner MJ, Kwan GF, Longenecker CT. Cardiovascular complications of HIV in endemic countries. Curr Cardiol Rep. 2016;18(11):113.CrossRefPubMedPubMedCentral
39.
go back to reference Barr EL, Tonkin AM, Welborn TA, Shaw JE. Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study. Intern Med J. 2009;39(1):49–53.CrossRefPubMed Barr EL, Tonkin AM, Welborn TA, Shaw JE. Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study. Intern Med J. 2009;39(1):49–53.CrossRefPubMed
40.
go back to reference McLaughlin MM, Durstenfeld MS, Gandhi M, Greene M, Ma Y, Beatty AL, Hsue PY. Cardiovascular health among persons with HIV without existing atherosclerotic cardiovascular disease. AIDS. 2023;37(14):2179–83.CrossRefPubMed McLaughlin MM, Durstenfeld MS, Gandhi M, Greene M, Ma Y, Beatty AL, Hsue PY. Cardiovascular health among persons with HIV without existing atherosclerotic cardiovascular disease. AIDS. 2023;37(14):2179–83.CrossRefPubMed
41.
go back to reference Yang X, Zhang J, Chen S, Weissman S, Olatosi B, Li X. Utilizing electronic health record data to understand comorbidity burden among people living with HIV: a machine learning approach. Aids. 2021;35(Suppl 1):S39–51.CrossRefPubMed Yang X, Zhang J, Chen S, Weissman S, Olatosi B, Li X. Utilizing electronic health record data to understand comorbidity burden among people living with HIV: a machine learning approach. Aids. 2021;35(Suppl 1):S39–51.CrossRefPubMed
42.
go back to reference Talbot D, Mésidor M, Chiu Y, Simard M, Sirois C. An alternative perspective on the Robust Poisson Method for estimating risk or prevalence ratios. Epidemiology. 2023;34(1):1–7.CrossRefPubMed Talbot D, Mésidor M, Chiu Y, Simard M, Sirois C. An alternative perspective on the Robust Poisson Method for estimating risk or prevalence ratios. Epidemiology. 2023;34(1):1–7.CrossRefPubMed
Metadata
Title
The dynamic risk factors of cardiovascular disease among people living with HIV: a real-world data study
Authors
Ziang Liu
Jiajia Zhang
Xueying Yang
Haoyuan Gao
Shujie Chen
Sharon Weissman
Bankole Olatosi
Xiaoming LI
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18672-x

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue